Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;31(1):11-8.
doi: 10.1111/j.1530-0277.2006.00259.x.

The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats

Affiliations

The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats

Brendan M Walker et al. Alcohol Clin Exp Res. 2007 Jan.

Abstract

Background: Gamma-aminobutyric acid-B (GABA(B)) receptor agonists have been shown to suppress operant self-administration of ethanol in nondependent rats. However, little work has focused on the effects of GABA(B) receptor agonists on self-administration of ethanol in dependent animals.

Methods: In the present experiment, the GABA(B) receptor agonist baclofen was tested for the ability to modulate both fixed- (FR) and progressive-ratio (PR) responding for ethanol in rats while nondependent and subsequently after ethanol dependence induction. Following the acquisition and stabilization of baseline operant ethanol self-administration and after dependence induction, baclofen [0.0, 0.5, 1, 2, and 4 mg/kg, intraperitoneal (IP)] was tested on FR-1 responding for ethanol. The ability of baclofen (2.0 mg/kg) to affect responding under a PR schedule of reinforcement was also evaluated. Dependence was induced in the animals by subjecting them to a 1-month intermittent vapor-exposure period in which animals were exposed to ethanol vapor for 14 h/d. Following the 1-month period, the vapor-exposed animals resumed FR-1 and PR baclofen drug testing (doses as described above) in the operant chambers at a time point corresponding to the animals being 6 hours into withdrawal (i.e., 6 hours after the ethanol vapor had been discontinued for that day).

Results: Baclofen (0.0, 0.5, 1, 2, and 4 mg/kg, IP) dose-dependently decreased ethanol self-administration in both nondependent and dependent rats on a FR schedule of reinforcement. However, the dose of baclofen that significantly reduced responding for ethanol was shifted to the left in the ethanol vapor-exposed animals, indicating an increased sensitivity to baclofen in animals that were chronically exposed to ethanol. When tested using a PR schedule of reinforcement, there was a significant increase in the breakpoint for the vapor-exposed animals (i.e., the animals were willing to work more in a dependent state). Baclofen (2.0 mg/kg, IP) suppressed intake for both nondependent and dependent animals.

Conclusions: Ethanol dependence produced increased self-administration of ethanol as reflected in increased ethanol intake and increased responding on a PR schedule of reinforcement. As baclofen suppressed ethanol self-administration and showed evidence of increased potency in dependent animals, the present experiment suggests that the GABA(B) receptor could be a potential pharmacotherapeutic target for the treatment of chronic alcoholism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mean (±SEM) lever-presses during the acquisition of ethanol and water operant self-administration, which clearly display a separation between ethanol and water responding as well as a maintained stability in responding.
Fig. 2
Fig. 2
Mean (+SEM) breakpoints for ethanol over 18 sessions.
Fig. 3
Fig. 3
Mean (+SEM) lever-presses for ethanol and water following baclofen (0.0, 0.5, 1, 2, and 4 mg/kg) challenge in nondependent and ethanol-dependent states (# #p<0.01 when comparing the vapor-naïve and vapor-exposed conditions; *p<0.05 and **p<0.01 when compared with the appropriate vapor-naïve or vapor-exposed vehicle control).
Fig. 4
Fig. 4
Mean (+SEM) ethanol consumption (g/kg) following baclofen (0.0, 0.5, 1, 2, and 4 mg/kg) challenge in nondependent and ethanol-dependent states (# #p<0.01 when comparing the vapor-naïve and vapor-exposed vehicle conditions; *p<0.05 and **p<0.01 when compared with the appropriate vapor-naïve or vapor-exposed vehicle control).
Fig. 5
Fig. 5
Mean (+SEM) breakpoints for ethanol with and without baclofen pretreatment while in nondependent and ethanol-dependent states (**p<0.01 for main effect of vapor exposure on ethanol self-administration; # #p<0.01 for main effect of baclofen on progressive-ratio breakpoints).
Fig. 6
Fig. 6
Mean (+SEM) cumulative responses for ethanol with and without baclofen pretreatment while in nondependent and ethanol-dependent states (***p<0.001 for main effect of vapor-exposure; #p<0.05 for main effect of baclofen on cumulative responding).
Fig. 7
Fig. 7
Mean cumulative responses for ethanol over the 180-minute progressive-ratio session while in nondependent and ethanol-dependent states. Ethanol-dependent animals worked longer and harder to obtain ethanol than when in their nondependent state.

References

    1. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 2002a;37:504–508. - PubMed
    1. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Colombo G, Gessa GL, Gasbarrini G. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med. 2002b;112:226–229. - PubMed
    1. Addolorato G, Leggio L, Abenavoli L, DeLorenzi G, Parente A, Caputo F, Janiri L, Capristo E, Rapaccini GL, Gasbarrini G. Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin Neuropharmacol. 2003;26:258–262. - PubMed
    1. Anstrom KK, Cromwell HC, Markowski T, Woodward DJ. Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol Clin Exp Res. 2003;27:900–908. - PubMed
    1. Ariwodola OJ, Weiner JL. Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J Neurosci. 2004;24:10679–10686. - PMC - PubMed

Publication types